Company / Current Assets per Share
Vistagen Therapeutics, Inc. Current Assets per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.44
FY2021
5-year range
$2.16 / $2.44
FY2017-FY2021
Trend
+13.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 6 years, ranging from $0.02 in FY2012 to $2.44 in FY2021.
Based on SEC 10-K filings.
2.44 in FY2021 with a 10-year CAGR of +49.0%.
Improved from $2.17 to $2.44 over the past 4 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +4.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- +49.0%
Key checks
Key Insights
- In FY2021, current assets per share increased 13.0% year-over-year.
- Lowest current assets per share in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $2.44 | +13.0% |
| FY2018 | $2.16 | -0.2% |
| FY2017 | $2.17 | +5738.6% |
| FY2014 | $0.04 | +73.0% |
| FY2012 | $0.02 | -52.8% |
| FY2011 | $0.05 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026